Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
10,685,598
-
Share change
-
+5,679,591
-
Total reported value
-
$448,622,275
-
Price per share
-
$41.98
-
Number of holders
-
55
-
Value change
-
+$240,819,340
-
Number of buys
-
43
-
Number of sells
-
11
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2015
As of 31 Mar 2015 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,685,598 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, Polaris Venture Management Co. V, L.L.C., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, Lamond Capital Partners LLC, RS INVESTMENT MANAGEMENT CO LLC, FEDERATED INVESTORS INC /PA/, Ballentine Partners, LLC, and Pentwater Capital Management LP.
This table shows 55 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.